Monica Gandhi
#38,325
Most Influential Person Now
American physician and academic researcher
Monica Gandhi's AcademicInfluence.com Rankings
Monica Gandhimedical Degrees
Medical
#576
World Rank
#777
Historical Rank
Public Health
#178
World Rank
#185
Historical Rank
Monica Gandhiphilosophy Degrees
Philosophy
#9336
World Rank
#12876
Historical Rank
Logic
#7098
World Rank
#8739
Historical Rank
Download Badge
Medical Philosophy
Monica Gandhi's Degrees
- Doctorate Medicine Harvard University
- Masters Public Health University of California, Berkeley
Why Is Monica Gandhi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Monica Gandhi is an American physician and professor. She teaches medicine at the University of California, San Francisco and is director of the UCSF Gladstone Center for AIDS Research and the medical director of the San Francisco General Hospital HIV Clinic, Ward 86. Her research considers HIV prevalence in women, as well as HIV treatment and prevention. She has been noted as a critic of some aspects of the COVID-19 lockdowns in the US.
Monica Gandhi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 (2020) (963)
- Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. (2006) (240)
- Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer (2020) (177)
- Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine. (2020) (176)
- Does patient sex affect human immunodeficiency virus levels? (2002) (163)
- The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting (2017) (158)
- [Sex differences in pharmacokinetics and pharmacodynamics]. (2004) (149)
- Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP) (2014) (124)
- Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. (2011) (121)
- Sex differences in pharmacokinetics and pharmacodynamics. (2004) (110)
- Low Lopinavir Plasma or Hair Concentrations Explain Second-Line Protease Inhibitor Failures in a Resource-Limited Setting (2011) (110)
- Poverty, unstable housing, and HIV infection among women living in the United States (2007) (100)
- Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir (2018) (98)
- Protease inhibitor levels in hair strongly predict virologic response to treatment (2009) (95)
- Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols (2005) (90)
- The interplay between HIV and COVID-19: summary of the data and responses to date (2020) (87)
- Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women (2006) (87)
- Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. (2008) (84)
- Antiretroviral Concentrations in Small Hair Samples as a Feasible Marker of Adherence in Rural Kenya (2014) (80)
- Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms (2021) (77)
- Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States (2018) (76)
- SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay (2021) (73)
- SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study (2021) (73)
- Loneliness in Older Adults Living with HIV (2018) (72)
- Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures (2014) (70)
- Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. (2004) (67)
- Common clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected women (2014) (67)
- A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV‐Positive Patients (2017) (64)
- Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study (2020) (64)
- A mentor training program improves mentoring competency for researchers working with early-career investigators from underrepresented backgrounds (2015) (64)
- Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring. (2015) (64)
- Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. (2016) (63)
- SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco (2020) (63)
- Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. (2015) (61)
- Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions (2020) (60)
- RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. (2019) (59)
- A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. (2012) (59)
- Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. (2020) (58)
- HIV pre-exposure prophylaxis for women (2016) (57)
- Single-pill combination regimens for treatment of HIV-1 infection. (2014) (56)
- Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women (2015) (56)
- Analysis of pharmacogenetic traits in two distinct South African populations (2011) (55)
- Hair and Plasma Data Show That Lopinavir, Ritonavir, and Efavirenz All Transfer From Mother to Infant In Utero, But Only Efavirenz Transfers via Breastfeeding (2013) (54)
- Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation (2018) (53)
- SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay (2021) (47)
- Creating More Effective Mentors: Mentoring the Mentor (2016) (47)
- Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women--The Women's Interagency HIV Study. (2016) (47)
- Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. (2009) (47)
- Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco (2016) (46)
- Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women (2015) (46)
- Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. (2009) (46)
- Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value (2017) (45)
- “The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV (2017) (45)
- Understanding the Disparity: Predictors of Virologic Failure in Women Using Highly Active Antiretroviral Therapy Vary by Race and/or Ethnicity (2013) (45)
- Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV‐infected pregnant and breastfeeding women in tororo, uganda (2014) (45)
- Hair It Is: The Long and Short of Monitoring Antiretroviral Treatment (2002) (45)
- Degree of Housing Instability Shows Independent “Dose-Response” With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus (2018) (44)
- Short communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings. (2014) (44)
- Erratum: Does patient sex affect human immunodeficiency virus levels? (Clinical Infectious Diseases (2002) 35 (313-322)) (2002) (44)
- Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine (2019) (43)
- Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda (2015) (43)
- Drug Overdose Deaths Before and After Shelter-in-Place Orders During the COVID-19 Pandemic in San Francisco (2021) (43)
- Behavioral Intervention Improves Treatment Outcomes Among HIV-Infected Individuals Who Have Delayed, Declined, or Discontinued Antiretroviral Therapy: A Randomized Controlled Trial of a Novel Intervention (2015) (43)
- Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol (2017) (43)
- Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients (2015) (43)
- Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States (2013) (41)
- A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans (2014) (41)
- Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network (2019) (40)
- Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen (2017) (40)
- Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis. (2017) (40)
- Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity (2021) (39)
- Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco (2020) (39)
- COVID-19 Susceptibility and Outcomes Among People Living With HIV in San Francisco (2020) (38)
- Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry (2011) (38)
- Implementation and Operational Research: Pulling the Network Together: Quasiexperimental Trial of a Patient-Defined Support Network Intervention for Promoting Engagement in HIV Care and Medication Adherence on Mfangano Island, Kenya (2015) (37)
- Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. (2018) (36)
- Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19 (2021) (36)
- Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination (2018) (36)
- Missed opportunities to prevent HIV infections among pre‐exposure prophylaxis users: a population‐based mixed methods study, San Francisco, United States (2020) (35)
- Targeting imported malaria through social networks: a potential strategy for malaria elimination in Swaziland (2013) (35)
- Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence (2018) (35)
- Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children. (2015) (35)
- Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. (2007) (34)
- Tenofovir Use and Urinary Biomarkers Among HIV-Infected Women in the Women's Interagency HIV Study (WIHS) (2013) (34)
- Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test (2019) (34)
- Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis. (2018) (33)
- Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial (2018) (33)
- Movement between facilities for HIV care among a mobile population in Kenya: transfer, loss to follow-up, and reengagement (2016) (32)
- Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations (2020) (32)
- Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis. (2017) (31)
- A multinational Delphi consensus to end the COVID-19 public health threat (2022) (31)
- The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting. (2012) (30)
- Nonnucleoside Reverse Transcriptase Inhibitor Pharmacokinetics in a Large Unselected Cohort of HIV-Infected Women (2009) (29)
- Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement (2021) (29)
- Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics. (2019) (28)
- Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa. (2019) (27)
- Uniting Infectious Disease and Physical Science Principles on the Importance of Face Masks for COVID-19 (2020) (27)
- Development and Validation of the First Point-of-Care Assay to Objectively Monitor Adherence to HIV Treatment and Prevention in Real-Time in Routine Settings. (2020) (27)
- Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System (2018) (27)
- Association Between Living With Children and Adherence to Highly Active Antiretroviral Therapy in the Women's Interagency HIV Study (2008) (27)
- Development and implementation of a workshop to enhance the effectiveness of mentors working with diverse mentees in HIV research. (2014) (26)
- HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. (2021) (26)
- Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment (2017) (25)
- "Wan Kanyakla" (We are together): Community transformations in Kenya following a social network intervention for HIV care. (2015) (25)
- Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. (2014) (24)
- Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania (2018) (24)
- A group-based mental health intervention for young people living with HIV in Tanzania: results of a pilot individually randomized group treatment trial (2020) (23)
- Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. (2017) (23)
- Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study. (2021) (23)
- SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco (2020) (22)
- Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy (2017) (22)
- Implementation challenges for long-acting antivirals as treatment (2015) (21)
- Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial (2018) (21)
- A retrospective cohort analysis comparing pregnancy rates among HIV-positive women using contraceptives and efavirenz- or nevirapine-based antiretroviral therapy in Kenya (2015) (20)
- A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study (2018) (20)
- Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project (2019) (20)
- The Time for Universal Masking of the Public for Coronavirus Disease 2019 Is Now (2020) (20)
- Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco (2018) (20)
- confUrine Tenofovir Concentrations Correlate with Plasma and Relates to TDF Adherence: A Randomized Directly-observed Pharmacokinetic Trial (TARGET Study). (2020) (20)
- HIV and women in the USA: what we know and where to go from here (2021) (19)
- Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy (2017) (18)
- Prevalence of Human Herpesvirus-8 Salivary Shedding in HIV Increases with CD4 Count (2004) (18)
- RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population. (2019) (18)
- Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART (2018) (17)
- Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial (2018) (17)
- Addressing the Sexually Transmitted Infection and HIV Syndemic. (2019) (17)
- Effectiveness of Adding a Mask Recommendation to Other Public Health Measures (2021) (17)
- Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection (2015) (17)
- Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention (2020) (16)
- Evaluation of a novel community-based COVID-19 'Test-to-Care model' for low-income populations (2020) (16)
- Increase of perceived frequency of neighborhood domestic violence is associated with increase of women's depression symptoms in a nationally representative longitudinal study in South Africa. (2015) (16)
- Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women’s Health Study (2015) (16)
- Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women’s Interagency HIV Study (2017) (15)
- Mentoring the Mentors: Implementation and Evaluation of Four Fogarty-Sponsored Mentoring Training Workshops in Low-and Middle-Income Countries (2018) (15)
- Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India (2019) (15)
- COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns (2021) (14)
- Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence (2019) (14)
- Motivational Interviewing to Reduce Drug Use and HIV Incidence Among Young Men Who Have Sex With Men in Relationships and Are High Priority for Pre-Exposure Prophylaxis (Project PARTNER): Randomized Controlled Trial Protocol (2019) (14)
- Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here (2021) (14)
- COVID-19 and HIV spotlight the U.S. imperative for permanent affordable housing (2020) (14)
- Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. (2019) (13)
- Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection (2022) (13)
- Brief Report: Cocaine Use and Pre-exposure Prophylaxis Adherence, Care Engagement, and Kidney Function (2019) (13)
- Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis (2016) (13)
- Acceptability and Feasibility of Self-Collecting Biological Specimens for HIV, Sexually Transmitted Infection, and Adherence Testing Among High-Risk Populations (Project Caboodle!): Protocol for an Exploratory Mixed-Methods Study (2019) (12)
- Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort (2019) (12)
- Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach. (2020) (12)
- Human herpesvirus 8, Kaposi's sarcoma, and associated conditions. (2002) (12)
- Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study (2019) (12)
- Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals (2018) (12)
- Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring (2017) (12)
- Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation. (2008) (11)
- Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial (2019) (11)
- Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry. (2018) (10)
- Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT (2019) (10)
- COVID-19 Outcomes and Risk Factors Among People Living with HIV (2022) (10)
- Improving Care Outcomes for PLWH Experiencing Homelessness and Unstable Housing: a Synthetic Review of Clinic-Based Strategies (2020) (10)
- Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19 (2021) (10)
- The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation. (2011) (10)
- Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. (2019) (10)
- Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based program (2020) (10)
- Low rate of sex-specific analyses in presentations at the Conference of Retroviruses and Opportunistic Infections (CROI) meeting, 2018: Room to improve. (2019) (10)
- Social Support Mitigates Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya (2020) (10)
- The Golden Compass Program: Overview of the Initial Implementation of a Comprehensive Program for Older Adults Living with HIV (2020) (10)
- Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel. (2019) (9)
- TransPrEP: Results from the Pilot Study of a Social Network-Based Intervention to Support PrEP Adherence Among Transgender Women in Lima, Peru (2021) (9)
- HIV pre-exposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health. (2019) (9)
- Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study (2018) (9)
- Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis (2019) (9)
- The Lorenz curve: a novel method for understanding viral load distribution at the population level (2017) (9)
- Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. (2008) (9)
- Tenofovir-based PrEP for COVID-19: an untapped opportunity? (2021) (9)
- Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection. (2022) (8)
- SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV (2021) (8)
- First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic (2022) (8)
- HIGH ACCURACY OF A REAL-TIME URINE ANTIBODY-BASED TENOFOVIR POINT-OF-CARE TEST COMPARED TO LABORATORY-BASED ELISA IN DIVERSE POPULATIONS. (2020) (8)
- Individual and partnership factors associated with anticipated versus actual partner notification following STI diagnosis among men who have sex with men and/or with transgender women in Lima, Peru (2017) (8)
- Treatment switching in South Indian patients on HAART: what are the predictors and consequences? (2011) (8)
- Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation. (2018) (8)
- Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here. (2021) (7)
- Isoniazid hair concentrations in children with tuberculosis: a proof of concept study. (2016) (7)
- A Position Statement on Mpox as a Sexually Transmitted Disease. (2022) (7)
- Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery (2021) (7)
- Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. (2007) (7)
- COVID-19 Mitigation With Appropriate Safety Measures in an Essential Workplace: Lessons for Opening Work Settings in the United States During COVID-19 (2021) (7)
- Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project. (2019) (7)
- Pilot Randomized Controlled Trial of Motivational Interviewing with Sexual Minority Male Couples to Reduce Drug Use and Sexual Risk: The Couples Health Project (2021) (7)
- Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study (2021) (7)
- Hair as a biological marker of daily oral pre-exposure prophylaxis (PrEP) adherence and tenofovir/emtricitabine (TFV/FTC) exposure in the global iPrEx study (2011) (7)
- Highly Active Antiretroviral Therapy Reduces Urinary Albumin Excretion in Women With HIV Infection (2008) (7)
- Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring. (2018) (7)
- Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB (2019) (7)
- Evaluating the Impact of Housing Status on Gonorrhea and Chlamydia Screening in an HIV Primary Care Setting (2019) (7)
- PrEP Demonstration Project Showed Superior Adherence with Tenofovir Alafenamide/Emtricitabine Compared to Tenofovir Disoproxil Fumarate/Emtricitabine in a Sample of Partnered Sexual Minority Men (2020) (7)
- Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing. (2021) (6)
- Patient and clinician perspectives on optimizing graphical displays of longitudinal medication adherence data. (2019) (6)
- Higher tenofovir concentrations in hair are associated with decreases in viral load and not self-reported adherence in HIV-infected adolescents with second line virological treatment failure. (2021) (6)
- Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection (2020) (6)
- Similar tenofovir hair concentrations in men and women after directly-observed: dosing of TDF/FTC: implications for PrEP adherence monitoring. (2018) (6)
- A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum (2021) (6)
- Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing (2021) (6)
- Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis (2017) (5)
- A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs. (2016) (5)
- Willingness to Donate Hair Samples for Research Among People Living with HIV/AIDS Attending a Tertiary Health Facility in Ibadan, Nigeria. (2019) (5)
- Drug resistance, rather than low tenofovir levels in blood or urine, is associated with tenofovir, emtricitabine and efavirenz (TEE) failure in resource-limited settings. (2021) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair. (2017) (5)
- Coronavirus Disease 2019 (COVID-19) and HIV Spotlight the United States Imperative for Permanent Affordable Housing (2020) (5)
- Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV (2020) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Using Real-Time Adherence Feedback to Enhance Communication About Adherence to Antiretroviral Therapy: Patient and Clinician Perspectives. (2020) (5)
- Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial (2022) (4)
- Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes. (2021) (4)
- Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach (2020) (4)
- The feminization of an epidemic. Women and HIV in the United States. (2009) (4)
- Plasma Pharmacokinetics and Urinary Excretion of Tenofovir Following Cessation in Adults with Controlled Levels of Adherence to Tenofovir Disoproxil Fumarate. (2020) (4)
- Masks Reduce Viral Inoculum of SARS-CoV2 (2021) (4)
- The Drinkers’ Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial (2021) (4)
- A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients (2016) (4)
- Preferences for conditional economic incentives to improve pre-exposure prophylaxis adherence: A discrete choice experiment among male sex workers in Mexico (2021) (4)
- Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples. (2020) (4)
- An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women. (2012) (4)
- Equity in access to long-acting injectables in the USA. (2022) (4)
- Association of Self-Reported Adherence and Antiretroviral Drug Concentrations in Hair Among Youth with Virologic Failure in Tanzania (2017) (4)
- Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study) (2020) (4)
- Short-term garlic supplementation and highly active antiretroviral treatment adherence, CD4+ cell counts, and human immunodeficiency virus viral load. (2012) (4)
- Short-Term Adherence Marker to PrEP Predicts Future Non-Retention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. (2019) (4)
- Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria (2021) (4)
- Determinants of Viral Resuppression or Persistent Virologic Failure After Initial Failure With Second-Line Antiretroviral Treatment Among Asian Children and Adolescents With HIV. (2019) (3)
- Tenofovir and Emtricitabine Concentrations in Hair are Comparable between Individuals on Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide-based ART. (2021) (3)
- Limitations of using the Lorenz curve framework to understand the distribution of population viral load: authors' reply. (2017) (3)
- Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment. (2020) (3)
- Use of Drug-Level Testing and Single-Genome Sequencing to Unravel a Case of HIV Seroconversion on PrEP. (2020) (3)
- A mentor training workshop focused on fostering diversity engenders lasting impact on mentoring techniques: Results of a long-term evaluation (2021) (3)
- Impact of Tamoxifen on Vorinostat-Induced HIV Expression in Women on Antiretroviral Therapy (ACTG A5366:The MOXIE trial). (2022) (3)
- 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report (2018) (3)
- Decrease in Hospitalizations for COVID-19 after Mask Mandates in 1083 U.S. Counties (2020) (3)
- Antiretroviral concentrations in hair strongly predict virologic response in a large HIV treatment-naive clinical trial. (2018) (3)
- HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness. (2022) (3)
- Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP). (2020) (3)
- A COVID-19 conference at AIDS 2020: Virtual (2020) (3)
- Understanding preferences for HIV care among patients experiencing homelessness or unstable-housing: A discrete choice experiment. (2020) (3)
- Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases – Authors' reply (2021) (2)
- The importance of PrEP persistence in preventing HIV infections on PrEP (2020) (2)
- Distinct forms of migration and mobility are differentially associated with HIV treatment adherence (2022) (2)
- Post-Mrna Vaccination SARS-CoV-2 IGG Concentrations and Surrogate Virus Neutralization Response Compared by HIV Status and Type of Vaccine: A Matched Case-Control Observational Study (2021) (2)
- LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV (2021) (2)
- 1607Veterans Aging Cohort Study (VACS) Index, Functional Status, and Other Patient Reported Outcomes in Older HIV-positive (HIV+) Adults (2014) (2)
- Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies (2015) (2)
- Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes (2021) (2)
- Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment (2021) (2)
- Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples. (2020) (2)
- Urine Tenofovir Levels Measured by a Novel Immunoassay Predict HIV Protection. (2020) (2)
- Facial Masking for Covid-19. Reply. (2020) (2)
- New boosters are here! Who should receive them and when? (2022) (2)
- Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers (2021) (2)
- Motivational Interviewing to Reduce Drug Use and HIV Incidence Among Young Men Who Have Sex With Men in Relationships and Are High Priority for Pre-Exposure Prophylaxis (Project PARTNER): Randomized Controlled Trial Protocol (Preprint) (2018) (2)
- Examining the Impact of the Golden Compass Clinical Care Program for Older People with HIV: A Qualitative Study (2021) (2)
- High Acceptability of Donating Hair and other Biological Samples for Research Among People Living with HIV in an Outpatient Clinic in Lagos, Nigeria. (2021) (2)
- Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting (2021) (2)
- Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure (2023) (1)
- Eligibility Criteria for HIV Clinical Trials: Disclosure, Impact on Enrollment and Generalizability (2004) (1)
- Antiretroviral Hair Levels, Self-Reported Adherence and Virologic Failure in Second-Line Regimen Patients in Resource-Limited Settings. (2021) (1)
- Immunity Against the Omicron Variant from Vaccination, Recovery or Both. (2022) (1)
- Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis (2020) (1)
- Disparities in Integrase Inhibitor Usage in the Modern HIV Treatment Era: A Population-Based Study in a US City (2021) (1)
- 2272. High Interest in Doxycycline for Sexually Transmitted Infection Post-Exposure Prophylaxis (Doxy-PEP) in a Multi-city Survey of Men Having Sex With Men (MSM) Using a Social-Networking App (2018) (1)
- Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens (2022) (1)
- The impact of COVID-19 on mentoring early-career investigators (2021) (1)
- Perceptions and Experiences of Returning Self-collected Specimens for HIV, Bacterial STI and Potential PrEP Adherence Testing among Sexual Minority Men in the United States (2022) (1)
- Targeting imported malaria through social networks: a potential strategy for malaria elimination in Swaziland (2013) (1)
- Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis (2020) (1)
- Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States. (2020) (1)
- Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates During Covid-19: An Interrupted Time Series Analysis (2021) (1)
- Machine Learning Algorithms Using Routinely Collected Data Do Not Adequately Predict Viremia to Inform Targeted Services in Postpartum Women Living With HIV (2021) (1)
- Study Evaluating Self-Collected Specimen Return for HIV, Bacterial STI, and Potential Pre-Exposure Prophylaxis Adherence Testing Among Sexual Minority Men in the United States (2022) (1)
- A Qualitative Study of the Experience of Immediate Antiretroviral Therapy Among Urban Persons With Newly Diagnosed Human Immunodeficiency Virus (2021) (1)
- Relationship Dynamics are Associated with Self-Reported Adherence but not an Objective Adherence Measure in Malawi (2022) (1)
- Four ways HIV activists have saved lives during Covid (2021) (1)
- Brief Report: No Difference in Urine Tenofovir Levels in Patients Living With HIV on Unboosted Versus Dose-Adjusted Boosted Tenofovir Alafenamide (2021) (1)
- Testing a social network approach to promote HIV self-testing and linkage to care among fishermen at Lake Victoria: study protocol for the Owete cluster randomized controlled trial (2022) (1)
- Screening for Covid-19 in Skilled Nursing Facilities. Reply. (2020) (1)
- Increased Social Support Mitigates the Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya (P04-126-19). (2019) (1)
- Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study (2021) (1)
- Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial (Preprint) (2019) (0)
- Brief Report: Use of Remnant Specimens to Assess Use of HIV PrEP Among Populations With Risk of HIV Infection: A Novel Approach (2022) (0)
- Evaluation of a Liquid Chromatography-Tandem Mass Spectrometry Assay for Second-line Tuberculosis Drug Concentrations in Small Hair Samples (2019) (0)
- Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria (2022) (0)
- Track B Clinical Science (2012) (0)
- Lessons Learned From the Implementation of a Pilot Study on Self-collected Specimen Return by Sexual Minority Men (Project Caboodle!): Qualitative Exploration (2023) (0)
- Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in Uganda (2022) (0)
- 1406. IMPACT (Infection Management Plus Addiction Care Together): A Combined Contingency Management Pilot for Substance Use Disorders & Antibiotic Adherence in the Acute Care Setting (2022) (0)
- Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring (2022) (0)
- Brief Report: Urine Tenofovir Levels Strongly Correlate with Virologic Suppression in Patients with HIV on Tenofovir Alafenamide-Based Antiretroviral Therapy. (2022) (0)
- Title Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial Permalink (2018) (0)
- PrEPare for Work: A Pilot Randomized Controlled Trial of an Intervention to Optimize HIV PrEP Outcomes Among Male Sex Workers. (2023) (0)
- Chapter 39 – Special issues regarding women with HIV infection (2012) (0)
- Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review (2023) (0)
- Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis (2022) (0)
- Late Breaker Oral Abstracts: HIV and Antibiotic Trials (2018) (0)
- 448. Disproportionate Burden of COVID-19 on Latinx Residents among Hospitalized Patients at San Francisco’s Public Health Hospital (2020) (0)
- Geriatric conditions and healthcare utilisation in older adults living with HIV. (2022) (0)
- Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States. (2020) (0)
- Diagnostic Accuracy of a Liquid Chromatography-Tandem Mass Spectrometry Assay for Rifampin-resistant Tuberculosis Drug Concentrations in a Routine Care Setting (2020) (0)
- Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial (2023) (0)
- Long-acting antiretrovirals and HIV treatment adherence. (2023) (0)
- Single-pill regimens for HIV-1 infection. (2014) (0)
- Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment (2022) (0)
- Mass Spectrometry Imaging of Hair Identifies Daily Maraviroc Adherence in HPTN 069/ACTG A5305 (2023) (0)
- A-104 Distinct mechanisms of hormonal control of HIV latency in T-cells and microglial cells (2016) (0)
- Self-Reported Use of HIV Preexposure Prophylaxis Is Highly Accurate Among Sexual Health Clinic Patients in New York City (2022) (0)
- Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair (2022) (0)
- “The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV (2016) (0)
- Details of COVID-19 Disease Mitigation Strategies in 17 K-12 Schools in Wood County, Wisconsin (2021) (0)
- Brief Report: Heterogeneous Preferences for Care Engagement Among People With HIV Experiencing Homelessness or Unstable Housing During the COVID-19 Pandemic (2022) (0)
- Acquisition of tenofovir-susceptible HIV despite consistently high level adherence to daily PrEP as measured by plasma, dried blood spot (DBS) and segmental hair analysis: a case report (2019) (0)
- Optimizing HIV Treatment (2018) (0)
- Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability. (2023) (0)
- The intertwined epidemics of HIV and COVID-19 - emerging data and responses. (2023) (0)
This paper list is powered by the following services:
Other Resources About Monica Gandhi
What Schools Are Affiliated With Monica Gandhi?
Monica Gandhi is affiliated with the following schools:
